4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
4.2400
03-7月-25 10:45:00
15 分の遅延
株式
-0.0700
-1.62%
本日の幅
4.1300 - 4.3400
ISIN
N/A
ソース
NASDAQ
-
02 7 2025 13:05:00 提供 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
28 5 2025 05:00:31 提供 Nasdaq GlobeNewswire
-
4DMT Announces New Employment Inducement Grants
16 5 2025 13:05:00 提供 Nasdaq GlobeNewswire
-
08 5 2025 13:05:03 提供 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
05 5 2025 05:00:21 提供 Nasdaq GlobeNewswire
-
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
01 5 2025 05:00:46 提供 Nasdaq GlobeNewswire
-
4DMT Announces New Employment Inducement Grants
11 4 2025 13:05:00 提供 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
27 3 2025 05:00:10 提供 Nasdaq GlobeNewswire
-
10 3 2025 05:00:00 提供 Nasdaq GlobeNewswire
-
28 2 2025 13:05:00 提供 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
19 2 2025 05:00:36 提供 Nasdaq GlobeNewswire
-
08 2 2025 11:30:24 提供 Nasdaq GlobeNewswire
-
29 1 2025 05:00:00 提供 Nasdaq GlobeNewswire
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
10 1 2025 05:00:00 提供 Nasdaq GlobeNewswire
-
10 1 2025 05:00:00 提供 Nasdaq GlobeNewswire
-
16 12 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV
14 11 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
13 11 2024 13:05:00 提供 Nasdaq GlobeNewswire
-
4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
23 9 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
18 9 2024 13:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >